Although a weakness of our study is that the relatively small size of the patient cohort inhibited our ability to make strong conclusions, noteworthy relationship was observed between polymorphisms of the CDKN1B and CCND2 genes and CLL course. The gene discussed is CDKN1B; the disease is B-cell chronic lymphocytic leukemia.